Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-02-11Investigating the Efficacy of a Top-Down Approach to Cognitive Remediation in Individuals With Affective Disorders
-
CLINICAL_TRIALS study record update · 2021-02-09KOREAN POST MARKETING SURVEILLANCE TO OBSERVE EFFECTIVENESS AND SAFETY OF PRISTIQ (REGISTERED) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.
-
CLINICAL_TRIALS study record update · 2021-02-01Feasibility and Acceptability of a Healthy Nordic Diet Intervention for the Treatment of Depression: a Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2021-01-29A Randomized, Double-blind, Double-dummy, Controlled Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide - a Pilot Study
-
CLINICAL_TRIALS study record update · 2021-01-22The Role of HNKs in the Antidepressant Effect of Ketamine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-01-15Music Therapy and Dialysis: A Pilot Investigation Into the Effectiveness of Patient-Selected Music Interventions on Physiological, Psychological, and Quality-of-Life Outcomes
-
CLINICAL_TRIALS study record update · 2021-01-13Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
-
CLINICAL_TRIALS study record update · 2021-01-12Investigating Predictors of Treatment Response in Treatment-Resistant Depression (TRD) With Interleaved TMS/fMRI
-
CLINICAL_TRIALS study record update · 2020-12-29A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-12-24A 52-week, Multi-center, Open-label Study of the Safety and Tolerability of Agomelatine Sublingual Tablets in Patients With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2020-12-24A 8-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of Agomelatine 0.5 mg and 1 mg Sublingual Tablets Administered Once Daily in Patients With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2020-12-23Brainsway Deep TMS System for Treatment of Major Depressive Disorder (MDD) Using Intermittent Theta Burst Stimulation (iTBS) Protocol
-
CLINICAL_TRIALS study record update · 2020-12-23An 8-week, Randomized, Double-blind, Fixed Dosage, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy, Safety and Tolerability of Agomelatine 25 mg and 50 mg in the Treatment of Major Depressive Disorder (MDD) Followed by a 52-week, Open-label Extension (CAGO178A2301E)
-
CLINICAL_TRIALS study record update · 2020-12-23A 52-week, Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel-group Study of the Long-term Efficacy, Tolerability and Safety of Agomelatine 25 and 50 mg in the Prevention of Relapse of Major Depressive Disorder (MDD) Following Open-label Treatment of 16-24 Weeks
-
CLINICAL_TRIALS study record update · 2020-12-23An 8-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of Agomelatine 0.5 mg and 1 mg Sublingual Tablets Administered Once Daily in Patients With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2020-12-23An 8-week, Multicenter, Randomized, Double-blind, Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine 25 or 50 mg Given Once Daily in the Treatment of Major Depressive Disorder (MDD) Followed by a 52-week Open-label Treatment With Agomelatine 25 or 50 mg
-
CLINICAL_TRIALS study record update · 2020-12-17The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental Health
-
CLINICAL_TRIALS study record update · 2020-12-17A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (5.0 mg or 2.5 mg) of MIN-117 in Adult Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-12-07Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
-
CLINICAL_TRIALS study record update · 2020-12-01"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"
-
CLINICAL_TRIALS study record update · 2020-11-25HEC113995-A Phase I,Double-Blind, Placebo-Controlled, Multiple Oral Dose, Safety, Tolerability, Pharmacokinetics and Food Effect Study in Healthy Chinese Subjects
-
CLINICAL_TRIALS study record update · 2020-11-12The Effectiveness of Group CBT and Exercise in Management of Depression: A Three Arm Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2020-11-10A Phase 1, Two Stage, Open Label, Randomized, Single Dose, Comparative Study to Evaluate the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine Product in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-11-09A Naturalistic Study of Serial Infusion of Low-dose Ketamine for Treatment Resistant Depressive Disorders in an Academic Psychiatric Hospital: The UTHealth Ketamine Project
-
CLINICAL_TRIALS study record update · 2020-11-09Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness